Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07486349 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Shoulder Pericapsular Block Versus Interscalene Block in Arthroscopic Shoulder Surgery

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Oct 1, 2026 → Dec 1, 2026
See other at-risk trials from Marmara University

Record History

  1. Recruitment opened Primary completion pushed from Oct 1, 2026 to Dec 1, 2026 · Eligibility criteria expanded, about 11 words Show 2 more changesShow less
    • Primary completion pushed from Oct 1, 2026 to Dec 1, 2026
    • Eligibility criteria expanded, about 11 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This randomized controlled trial aims to compare the incidence of hemidiaphragmatic paralysis (HDP) following ultrasound-guided interscalene block (ISB) versus shoulder pericapsular nerve group (PENG) block in patients undergoing elective shoulder surgery under general anesthesia. The primary objective is to determine whether the shoulder PENG block reduces the incidence of HDP compared with conventional intrafascial ISB. HDP will be assessed using ultrasound measurement of diaphragmatic excursion 30 minutes after block performance
Trial Details
NCT Number NCT07486349
Lead Sponsor Marmara University
Conditions Hemidiaphragmatic Paralysis
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov